4//SEC Filing
Valeant Pharmaceuticals International, Inc. 4
Accession 0000885590-15-000051
$BHCCIK 0000885590operating
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:01 PM ET
Size
4.9 KB
Accession
0000885590-15-000051
Insider Transaction Report
Form 4
Rosiello Robert L.
EVP, Chief Financial Officer
Transactions
- Purchase
Common Stock, no par value
2015-06-12$232.51/sh+12,900$2,999,379→ 12,900 total
Footnotes (1)
- [F1]This number represents the weighted average purchase price for all sales of common stock purchased by the reporting officer.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000885590
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:01 PM ET
- Size
- 4.9 KB